Ernakulam Court Summons Ramdev, Balkrishna In Drug Promotion Case

THIRUVANANTHAPURAM:  A court in Ernakulam has directed Baba Ramdev and Acharya Balkrishna of Divya Pharmacy to be present in the court in cases filed by the Drugs Control Department. The Judicial First Class Magistrate Court in Kakkanad issued two separate orders in connection with the illegal drug promotions.

The department accused both Ramdev and Acharya of violating Section 3(d) of Drugs and Magic Remedies (Objectionable Advertisements) Act in these cases. The court issued summons to the accused in one case on January 30 and issued directions for the production of the accused in another case on February 17 next year. Besides, the Additional Chief Judicial Magistrate in Thiruvananthapuram also issued notice to the same accused in another case filed by the department. The case is posted for November 21.

The Drugs Control Department has filed a total of 10 cases against Ramdev-promoted Divya Pharmacy for publishing misleading advertisements in various courts in Kozhikode (4 cases), Palakkad (3 cases), Ernakulam (2 cases) and Thiruvananthapuram (1 case).

The cases have been registered for violation of Section 3(d) of Drugs and Magic Remedies (Objectionable advertisement) Act 1954. Under the law, cure of 54 diseases listed in the schedule should not be advertised.

The state’s drugs control department became the first drug licensing agency in the country to file a case against Patanjali Ayurved in a court for publishing misleading advertisements in April.

The department found that Patanjali’s Divya Pharmacy advertised pharmaceutical products for diseases, in which the cure should not be advertised, in more than 30 instances. The cases were initiated based on a complaint filed by Dr Babu K V, a health activist from Kannur.

Related Posts

National Pharmaceutical Pricing Authority notifies retail price of 42 new drugs

New Delhi:  The National Pharmaceutical Pricing Authority (NPPA) has notified retail price of 42 new drugs under the provisions of the Drugs Prices Control Order (DPCO), 2013, including anti hypertensive,…

World’s First Malaria Treatment for Newborns and Young Infants Receives WHO Prequalification

New Delhi– In a landmark development for global child health, the World Health Organization (WHO) has granted prequalification to Coartem® Baby (artemether-lumefantrine), the first and only antimalarial medicine specifically developed…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

National Pharmaceutical Pricing Authority notifies retail price of 42 new drugs

National Pharmaceutical Pricing Authority notifies retail price of 42 new drugs

World’s First Malaria Treatment for Newborns and Young Infants Receives WHO Prequalification

World’s First Malaria Treatment for Newborns and Young Infants Receives WHO Prequalification

FIR Lodged Against Pharmacist in Chandauli for Working Nearly 10 Years on Forged Documents

FIR Lodged Against Pharmacist in Chandauli for Working Nearly 10 Years on Forged Documents

Laughing all the Way to Health with Sir Ganga Ram Hospital

Laughing all the Way to Health with Sir Ganga Ram Hospital

Semaglutide generics ‘stimulating’ Obesity market growth, says Eli Lilly’s Patrik Jonsson

Semaglutide generics ‘stimulating’ Obesity market growth, says Eli Lilly’s Patrik Jonsson

Pak-made illegal cosmetics recovered from Itwari shop

Pak-made illegal cosmetics recovered from Itwari shop